Reaction
Urticarial Vasculitis reporting signals
As of the last recalculation, Urticarial Vasculitis appears in 513 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is TERBINAFINE HYDROCHLORIDE (PRR 65.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Terbinafine Hydrochloride | 14 | 65.7 | 65.8 |
| Cefazolin | 11 | 50.0 | 50.0 |
| Colchicine | 28 | 45.6 | 45.6 |
| Daptomycin | 10 | 44.8 | 44.9 |
| Cefazolin Sodium | 11 | 37.8 | 37.9 |
| Daspone | 8 | 33.8 | 33.9 |
| Dapsone Gel, 5% | 8 | 33.8 | 33.9 |
| Omalizumab | 62 | 33.4 | 33.5 |
| Dapsone | 8 | 30.9 | 30.9 |
| Fexofenadine | 11 | 27.6 | 27.6 |
| Alpelisib | 4 | 18.8 | 18.8 |